Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies on the Safety, Tolerability, and Pharmacokinetics of Naldemedine in Healthy Volunteers
Clinical Pharmacology in Drug Development - United States
doi 10.1002/cpdd.387
Full Text
Open PDFAbstract
Available in full text
Date
September 27, 2017
Authors
Publisher
Wiley